GlassScriptPhysician profile
James S Burdick
NPI 1295791564
$4,457.43
in general payments reported to CMS, 2019-2025
9 companies · $2,281 in 2025
The $2,281 reported for 2025 was more than what 82% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $719 · 2020: $187 · 2021: $105 · 2022: $914 · 2023: $102 · 2024: $150 · 2025: $2,281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,899 · Food and Beverage: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,898.94 |
| Food and Beverage | $634.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $2,454.51 | 2019-2025 | Single Use Electrosurgical Knife Kd-655, Disposable Distal Attachment, Olympus |
| Apollo Endosurgery US INC | $929.13 | 2019-2022 | |
| Boston Scientific Corporation | $469.17 | 2019-2025 | Exalt Model D |
| Olympus America INC. | $307.32 | 2019-2022 | |
| Medtronic, INC. | $123.57 | 2025 | Endoflip |
| Conmed Corporation | $69.47 | 2021-2023 | Conmed Generators |
| Cook Medical LLC | $66.24 | 2019-2020 | |
| Erbe USA INC | $21.35 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $16.67 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Burdick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.